Evidence map›Paper›PMID 27493871›Full record

ArticleJournal of cachexia, sarcopenia and muscle2016

Degenerin channel activation causes caspase-mediated protein degradation and mitochondrial dysfunction in adult C. elegans muscle.

Christopher J Gaffney, Freya Shephard, Jeff Chu, David L Baillie, Ann Rose, Dumitru Constantin-Teodosiu, Paul L Greenhaff, Nathaniel J Szewczyk

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frailty andFrontiers in nutrition · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Christopher J GaffneyMRC/ARUK Centre for Musculoskeletal Ageing Research, Faculty of Medicine and Health Sciences University of Nottingham Nottingham NG7 2UH UK.
Freya ShephardMRC/ARUK Centre for Musculoskeletal Ageing Research, Faculty of Medicine and Health Sciences University of Nottingham Nottingham NG7 2UH UK.
Jeff ChuDepartment of Molecular Biology and Biochemistry Simon Fraser University Burnaby BCV5A 1S6 Canada; Department of Medical Genetics University of British Columbia Vancouver BCV6T 1Z4 Canada.
David L BaillieDepartment of Molecular Biology and Biochemistry Simon Fraser University Burnaby BC V5A 1S6 Canada.
Ann RoseDepartment of Medical Genetics University of British Columbia Vancouver BC V6T 1Z4 Canada.
Dumitru Constantin-TeodosiuMRC/ARUK Centre for Musculoskeletal Ageing Research, Faculty of Medicine and Health Sciences University of Nottingham Nottingham NG7 2UH UK.
Paul L GreenhaffMRC/ARUK Centre for Musculoskeletal Ageing Research, Faculty of Medicine and Health Sciences University of Nottingham Nottingham NG7 2UH UK.
Nathaniel J SzewczykMRC/ARUK Centre for Musculoskeletal Ageing Research, Faculty of Medicine and Health Sciences University of Nottingham Nottingham NG7 2UH UK.ORCID 0000-0003-4425-9746
University of Nottingham · GBUniversity of British Columbia · CASimon Fraser University · CA

Funding

Gene Networks Regulating Muscle Protein DegradationR01AR054342 · NIAMS · UNIVERSITY OF NOTTINGHAM · PI SZEWCZYK, NATHANIEL J. · 2007 to 2010
$902k
NIAMS NIH HHS R01 AR054342
6 · The paper itself

Abstract

backgroundDeclines in skeletal muscle structure and function are found in various clinical populations, but the intramuscular proteolytic pathways that govern declines in these individuals remain relatively poorly understood. The nematode Caenorhabditis elegans has been developed into a model for identifying and understanding these pathways. Recently, it was reported that UNC-105/degenerin channel activation produced muscle protein degradation via an unknown mechanism.

methodsGeneration of transgenic and double mutant C. elegans, RNAi, and drug treatments were utilized to assess molecular events governing protein degradation. Western blots were used to measure protein content. Cationic dyes and adenosine triphosphate (ATP) production assays were utilized to measure mitochondrial function.

resultsunc-105 gain-of-function mutants display aberrant muscle protein degradation and a movement defect; both are reduced in intragenic revertants and in let-2 mutants that gate the hyperactive UNC-105 channel. Degradation is not suppressed by interventions suppressing proteasome-mediated, autophagy-mediated, or calpain-mediated degradation nor by suppressors of degenerin-induced neurodegeneration. Protein degradation, but not the movement defect, is decreased by treatment with caspase inhibitors or RNAi against ced-3 or ced-4. Adult unc-105 muscles display a time-dependent fragmentation of the mitochondrial reticulum that is associated with impaired mitochondrial membrane potential and that correlates with decreased rates of maximal ATP production. Reduced levels of CED-4, which is sufficient to activate CED-3 in vitro, are observed in unc-105 mitochondrial isolations.

conclusionsConstitutive cationic influx into muscle appears to cause caspase degradation of cytosolic proteins as the result of mitochondrial dysfunction, which may be relevant to ageing and sarcopenia.

Indexed as

CaspaseC. elegansDegenerinMitochondriaMuscle

Identifiers

PMID27493871
PMCPMC4864282
OpenAlexW1588199288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.